Author:
Malur S.,Meerpohl H. G.,Beckmann M. W.
Publisher
Springer Berlin Heidelberg
Reference48 articles.
1. Acs G, Pasha T, Zhang PJ (200) WT1 is differentially expressed in serous, endometrioid, clear cell, andmucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. Int J Gynecol Pathol 23:110–118
2. Agoff SN, Garcia RL, Goff B, Swisher E (2004) Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations. Am J Surg Pathol 28:1112–1114
3. Alvarado-Cabrero I, Young RH, Vamvakas EC, Scully RE (1999) Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors. Gynecol Oncol 72:367–379
4. Baekelandt M, Jorunn Nesbakken A, Kristensen GB et al (2000) Carcinoma of the fallopian tube. Cancer 89:2076–2084
5. Beckmann MW, Minkwitz G von, Pfisterer J et al (2003) Stellungnahme der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO): Nachsorge beim Mammakarzinom und gynäkologischen Malignomen — “To follow-up or not to follow-up”. GebFra 63:725–730